Blog

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors – News-Medical.net

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors
News-Medical.net
The novel cellular therapy is called drug-resistant immunotherapy, or DRI. It is in its preclinical phase, and Incysus is moving toward an investigational new drug application filing with the U.S. Food and Drug Administration to begin tests of safety

2017-05-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.